All stocks · ORTINGLOBE
OG

ORTIN GLOBAL LIMITED

ORTINGLOBE BSE Drug Manufacturers - Specialty & Generic Healthcare

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; fo…

ISIN INE749B01020
Listed —
Quarters tracked 13
Filings 20 docs

About

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; research and development services for new formulation brands; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; operates as a merchant exporter of pharmaceutical finished formulations; and engages in real estate. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap13 Cr
P/E—
Div Yield0.00 %
Book Value—
52w High₹21.30
52w Low₹10.70
Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 0.01 0.30 0.01 0.01 0.08 0.09 0.03 0.05 0.21 0.30 0.14 0.27 1.57
Expenses 0.34 0.31 0.06 0.51 0.24 0.25 0.16 0.50 0.31 3.35 2.74 1.17 1.39
Operating Profit -0.33 -0.01 -0.05 -0.50 -0.16 -0.16 -0.13 -0.45 -0.10 -3.05 -2.60 -0.90 0.18
OPM % -3,300.00 -3.33 -500.00 -5,000.00 -200.00 -177.78 -433.33 -900.00 -47.62 -1,016.67 -1,857.14 -333.33 11.46
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.06 0.06 0.06
Interest 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.02 0.00 0.08 0.14 0.15 0.11
Profit before tax -0.33 -0.01 -0.05 -0.50 -0.16 -0.16 -0.10 -0.47 -0.10 -3.18 -2.80 -1.11 0.01
Tax % 0.00 0.00 0.00 0.00 6.25 0.00 10.00 0.00 0.00 30.19 -0.71 1.80 0.00
Net Profit -0.34 -0.01 -0.05 -0.50 -0.18 -0.16 -0.11 -0.47 -0.10 -4.14 -2.79 -1.12 0.02
EPS in Rs -0.42 -0.01 -0.06 -0.61 -0.22 -0.20 -0.14 -0.58 -0.12 -5.09 -3.43 -1.38 0.02

Profit & Loss

Annual · Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 0.410.342.016.008.238.16197.36167.5179.6361.5762.7260.29
Expenses 1.131.236.405.477.856.92191.66160.8374.2256.1256.8353.80
Operating Profit -0.72-0.89-4.390.530.381.245.706.685.415.455.896.49
OPM % -175.61-261.76-218.418.834.6215.202.893.996.798.859.3910.76
Other Income 0.000.06-1.980.010.190.050.180.130.450.320.570.00
Interest 0.000.000.480.400.810.873.213.223.492.943.423.52
Depreciation 0.000.010.230.250.290.291.961.751.691.701.651.64
Profit before tax -0.72-0.84-7.08-0.11-0.530.130.711.840.681.131.391.33
Tax % 2.781.1913.56-18.18-24.53-623.08181.6930.430.0055.7541.0132.33
Net Profit -0.74-0.85-8.04-0.09-0.400.95-0.561.280.680.500.830.90
EPS in Rs -0.91-1.05-9.89-0.11-0.491.17-0.330.760.400.300.490.53
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 8.138.138.138.138.138.1316.9416.9416.9416.9416.9416.94
Reserves -6.89-6.15-5.312.732.833.226.888.157.146.466.335.50
Borrowings 1.010.251.806.456.146.9419.5719.4717.3417.3420.8520.96
Other Liabilities 2.401.552.053.893.612.9773.1360.5332.2420.7921.2223.87
Total Liabilities 4.653.786.6721.2020.7121.26116.52105.0973.6661.5365.3467.27
Fixed Assets 0.010.000.0113.9614.2114.3822.4521.2920.0320.6921.6321.83
CWIP 0.000.000.000.430.430.430.430.530.400.350.000.00
Investments 0.000.000.000.000.000.000.070.080.080.070.030.03
Other Assets 4.643.786.666.816.076.4593.5783.1953.1540.4243.6845.41
Total Assets 4.653.786.6721.2020.7121.26116.52105.0973.6661.5365.3467.27

Cash Flows

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity -0.56-0.41-4.79-0.252.1518.033.306.521.561.940.52-1.38
Cash from Investing Activity 0.040.0012.000.01-0.130.07-3.09-3.27-0.90-1.26-0.860.22
Cash from Financing Activity 0.750.33-3.490.90-0.48-9.86-1.33-2.890.07-0.820.271.73
Net Cash Flow 0.23-0.093.720.661.558.25-1.120.370.73-0.14-0.070.58
Free Cash Flow -0.52-0.417.21-0.242.0218.030.283.380.770.83-0.92-1.38
CFO/OP % 78.0046.0080.00-47.00566.001,454.0072.00104.0040.0047.0017.00-14.00

Ratios

Annual · Days / % — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 178.05279.12321.42208.05143.69174.9068.7182.43100.1590.3553.13103.77
Inventory Days 0.0034.764.92279.94136.29169.10117.80100.07152.21158.21148.72192.30
Days Payable —69.527.87166.8961.88123.82155.80145.12143.09108.1024.82151.09
Cash Conversion Cycle 178.05244.36318.47321.10218.10220.1730.7037.38109.28140.45177.04144.97
Working Capital Days 730.001,524.41357.74-43.19-109.10-87.2211.2416.8241.4837.2916.2429.00
ROCE % -32.14-25.11-40.581.801.583.248.9411.779.449.5710.9212.07

Shareholding Pattern

% holding — latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 1.23 1.23 1.23 1.23 1.23 1.23 1.23 1.23 1.23 1.23 7.36 7.37
FIIs 1.80 1.68 1.68 1.68 6.53 6.53 6.25 6.25 6.25 0.00 0.00 0.00
Public 96.96 97.10 97.09 97.08 92.24 92.24 92.52 92.52 92.53 98.76 92.64 92.64
No. of Shareholders 11,383 11,452 11,834 12,060 12,034 12,144 12,094 12,165 11,952 12,192 12,314 11,836

Corporate Actions

4 records
ActionEx DateRecord DateRatioAmount (₹)Notes
Other 22 Sep 2023 — — — Annual General Meeting
Other 23 Sep 2022 — — — Annual General Meeting
Other 12 Jan 2021 13 Jan 2021 — — Spin Off
Other 12 Jan 2021 13 Jan 2021 — — Reduction of Capital

Announcements

5 filings

Shareholding Pattern

Open on BSE

Financial Results — Filings

Open on BSE

Board Filings

Open on BSE

Annual Reports

Back to all stocks